- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03156634
A Pilot Study of the Impact of the Patient Activated Learning System (PALS) on Knowledge Acquisition, Recall, and Decision Making
The Impact of the Patient Activated Learning System (PALS) on Knowledge Acquisition, Recall, and Decision Making About Antihypertensive Medication: A Pilot Study
Study Overview
Detailed Description
Primary research question:
1)Do hypertensive participants who learn about hypertension medication with PALS (intervention) have higher immediate and 1 week knowledge assessment scores than participants randomized to learn the same information via WebMD (control)? The investigators hypothesize that participants in the PALS group will have higher immediate and one week assessment scores.
Secondary research questions:
Do participants in the PALS group feel more informed to make hypothetical decisions about taking medications compared to participants in the WebMD group?
The investigators hypothesize that participants in the PALS group will be more likely to indicate that they have sufficient information to make hypothetical decisions about taking medications than participants in the WebMD group.
- Do participants in the PALS group rate it higher on user experience measures such as trust, usefulness, comprehensibility, and adequacy of the information, attractiveness of the site, and level of engagement, than those in the WebMD group? The investigators hypothesize ratings on these measures will be higher in the PALS group compared to the WebMD group.
- Which questions about antihypertensives do participants consider most important and are the 5 most highly rated questions more likely to be addressed on PALS vs. WebMD? The investigators hypothesize that PALS will address more questions that participants rate as important compared to WebMD.
Participants with hypertension, who have been prescribed any antihypertensive medicine except chlorthalidone will be recruited from the Weill Cornell Internal Medicine Associates (WCIMA) practice. Potentially eligible participants who have an upcoming appointment at WCIMA will be identified via a review of the electronic medical record. In cases where the participant's eligibility is unclear, Research Assistants (RA's) will contact the participant's Primary Medical Doctor (PMD) to confirm eligibility. Potentially eligible participants will be contacted via the telephone to assess their interest in participating and to schedule a study visit for those interested. Verbal consent will be obtained either on the phone or at the study visit. Potentially eligible participants may also be recruited from the waiting room at WCIMA if the RA's were unable to contact them by phone prior to their WCIMA visit.
Eligible participants who agree to participate will be randomized to view information about the antihypertensive, chlorthalidone, via the PALS or WebMD. The study procedures will be identical for both the PALS and WebMD groups.
Chlorthalidone was chosen because, despite its efficacy, it is not prescribed as often as other antihypertensives. This will allow the investigators to select a sample of participants who are less likely to have baseline knowledge of the information we are testing.
To assess knowledge acquisition and recall, participants will be shown up to 10 pre-specified webpages within their site of randomization that contain information that answers up to 10 discrete questions about chlorthalidone. Participants will answer up to 10 corresponding assessment questions immediately after viewing the information. The knowledge score will be the percentage of correct responses. The RA's will evaluate knowledge retention by asking the same assessment questions over the phone one week later. User experience, trust, and participant decision-making will be assessed through a survey and through a short semi structured interview. The investigators will also collect information on health literacy via the REALM-SF health literacy questionnaire as well as demographic information including age, level of education, race/ethnicity, prior Internet use, and access to the Internet.
To assess question prioritization/availability on PALS/WebMD, the investigators will show participants a list of up to 40 questions and ask them to chose those most important to them. The investigators will search for the answers to the highest prioritized questions to determine availability on PALS/WebMD.
Surveys and knowledge scores will be administered via Qualtrics. Participants will be compensated with a $25 ClinCard after completing the study visit.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10021
- Weill Cornell Internal Medicine Associates
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Weill Cornell Internal Medicine Associates (WCIMA) patients with hypertension who have been prescribed any antihypertensive medicine except chlorthalidone.
- Patients who meet the criteria above and are English speaking and without cognitive impairment or other medical condition that would impair or preclude their ability to participate (such as a serious medical condition).
Exclusion Criteria:
- WCIMA patients without hypertension
- WCIMA patients with hypertension who have not been prescribed antihypertensive medicine
- Patients who are non-English speaking
- Patients with cognitive impairment or other medical condition that would impair or preclude their ability to participate (such as a serious medical condition).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: PALS
Participants will view materials about the antihypertensive, chlorthalidone on the Patient Activated Learning System (PALS).
|
PALS is a web based patient education system that uses text and audiovisual formats to deliver patient education materials.
|
Active Comparator: WedMD
Participants will view materials about the antihypertensive, chlorthalidone on WebMD.
|
WebMD is an internet based health information source.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Knowledge acquisition
Time Frame: Immediate
|
Subjects will be asked questions about the materials they viewed.
|
Immediate
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recall
Time Frame: 1 week
|
Subjects will be asked questions about the materials they viewed.
|
1 week
|
User experience
Time Frame: Immediate
|
Participants will be asked about user experience including trust, usefulness, comprehensibility, and adequacy of the information, attractiveness of the site, and level of engagement of materials.
|
Immediate
|
Decision making
Time Frame: Immediate
|
Participants will be asked if they have sufficient information to make hypothetical decisions about taking chlorthalidone.
|
Immediate
|
Collaborators and Investigators
Investigators
- Principal Investigator: Amanda S Carmel, MD, Weill Medical College of Cornell University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1610017672
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Education
-
Istanbul University - Cerrahpasa (IUC)CompletedBariatric Surgery Candidate | Education | Patient EducationTurkey
-
Johns Hopkins UniversityTerminated
-
Milton S. Hershey Medical CenterCompletedPatient Education
-
Royal Devon and Exeter NHS Foundation TrustCompletedPatient Education
-
Centre Hospitalier Universitaire DijonCompleted
-
Francisco Javier Navarro MoyaAndaluz Health ServiceUnknownHealth Education | Blood Coagulation Tests | Patient Education as TopicSpain
-
Govert VeldhuijzenCompletedColonoscopy | eHealth | Education, Patient
-
University of Colorado, DenverColorado State UniversityWithdrawnVirtual Reality | Diagnostic Imaging | Patient Education | Cancer PatientUnited States
-
Basque Health ServiceUnknownHealth Promotion | Health Behavior | Health Education | Patient Education | Counseling | Behavior TherapySpain
-
The Hospital for Sick ChildrenSunnybrook Health Sciences CentreRecruitingWell-being | Education | Patient SafetyCanada
Clinical Trials on PALS
-
Weill Medical College of Cornell UniversityEnrolling by invitation
-
American University of Beirut Medical CenterCompleted
-
American University of Beirut Medical CenterCompleted
-
Weill Medical College of Cornell UniversityWithdrawn
-
The University of Texas Health Science Center,...CompletedGrowth & DevelopmentUnited States
-
The University of Texas Health Science Center,...Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruiting
-
University of PadovaCatholic University of the Sacred Heart; University of Florence; Università degli...Completed
-
Cornell UniversityCompletedCommunication | Health Knowledge, Attitudes, Practice | TrustUnited States
-
Jaeb Center for Health ResearchNational Eye Institute (NEI)Completed
-
University of WashingtonCenters for Disease Control and PreventionCompletedDiabetes Mellitus | AgingUnited States